Pathology Services Market Global Report 2026

The pathology services market size has grown strongly in recent years. It will grow from $33.78 billion in 2025 to $36.14 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to dependence on manual laboratory testing procedures, limited automation in diagnostic workflows, low adoption of molecular diagnostic technologies, shortage of skilled laboratory personnel, and fragmented healthcare laboratory infrastructure.

The pathology services market size is expected to see strong growth in the next few years. It will grow to $47.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to AI-enabled diagnostic interpretation systems, expansion of precision medicine adoption, growth in cloud-based pathology platforms, increasing demand for preventive healthcare screening, and integration of multi-omics and advanced molecular testing approaches. Major trends in the forecast period include rising adoption of molecular and genetic testing for precision diagnostics, increasing shift toward integrated laboratory automation in pathology workflows, expansion of decentralized and point-of-care pathology testing services, growing demand for multi-omics-based disease detection methods, and increasing use of predictive analytics for early disease identification and continuous monitoring.

The expansion of personalized and precision medicine is expected to propel the growth of the pathology services market going forward. Personalized and precision medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual’s unique genetic, molecular, and clinical profile. The increasing adoption of precision medicine is mainly fueled by rapid progress in genomic sequencing technologies, which have substantially lowered the cost and time required to generate patient-specific genetic data, enabling wider clinical use across healthcare systems. The growing expansion of personalized and precision medicine increases demand for pathology services, as they are crucial for performing genetic testing, biomarker evaluation, and molecular diagnostics that support individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six in 2022. Therefore, the expansion of personalized and precision medicine is driving the growth of the pathology services market.

Leading companies operating in the pathology services market are focusing on expanding artificial intelligence (AI)-powered digital pathology solutions to improve diagnostic precision, streamline laboratory workflows, and support pathologists in disease detection and analysis. AI-powered digital pathology solutions refer to advanced technologies that combine digital imaging, cloud-based platforms, and machine learning algorithms to assist in pathology interpretation, case review, and clinical decision-making. For example, in February 2026, Laboratory Corporation of America Holdings, a US-based life sciences and diagnostic company, expanded its collaboration with PathAI, a US-based biotechnology company, to deploy the AISight Dx, an FDA-cleared digital pathology image management system, across its laboratory network. It supports digital pathology workflows through case management, slide annotation, real-time collaboration, and seamless integration with laboratory information systems. The platform combines AI-driven image analysis with secure and scalable infrastructure to improve diagnostic accuracy, reduce manual errors, and enhance operational efficiency.

In July 2024, Quest Diagnostics, a US-based provider of diagnostic information services, laboratory testing, and pathology services, acquired the laboratory assets of PathAI Diagnostics from PathAI for an undisclosed amount. Through this acquisition, Quest Diagnostics aims to accelerate the integration of artificial intelligence and digital pathology technologies to improve cancer diagnosis and further enhance diagnostic efficiency and accuracy. PathAI is a US-based provider of digital and artificial intelligence-enabled pathology laboratory services focused on advancing precision diagnostics and supporting clinical applications as well as biopharmaceutical research.

Major companies operating in the pathology services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International Inc., Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs.

North America was the dominant region in the pathology services market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the pathology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pathology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pathology services market includes revenues earned by entities by providing services such as laboratory testing, diagnostic analysis, specimen collection, histopathology, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering, such as diagnostic kits, reagents, and testing consumables. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pathology services market research report is one of a series of new reports that provides pathology services market statistics, including pathology services industry global market size, regional shares, competitors with a pathology services market share, detailed pathology services market segments, market trends and opportunities, and any further data you may need to thrive in the pathology services industry. This pathology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.